Actavis Gaining More From Purchase Than Sale: Real M&A

Actavis Inc. stands to return 17 percent more to shareholders by acquiring birth-control drugmaker Warner Chilcott Plc than selling itself.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.